Our results revealed a correlation of TIM-3 expression of leukemic blasts with TIM-3 expression of both CD8+ and CD4+ T lymphocytes and the proportion of CD8+ T lymphocytes, indicating that TIM-3 expression of leukemic blasts might alter adaptive immunity of AML patients. This evidence concerns the gene CD8A and acute myeloid leukemia.